Work

Choice Is Good at Times: The Emergence of [ 64 Cu]Cu-DOTATATE–Based Somatostatin Receptor Imaging in the Era of [ 68 Ga]Ga-DOTATATE

Year: 2022

Type: article

Abstract: Somatostatin receptor (SSTR) imaging has brought about impactful changes in clinical management of neuroendocrine tumors (NETs), including pheochromocytoma and paraganglioma (PPGL) ([ 1 ][1] , [ 2 ][2]). It allows tumor detection and disease characterization and is mandatory for selecting patients

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.122.264183

Authors: Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Clara C. Chen, Corina Millo, Roberto Maass-Moreno, Alexander Ling, Frank I. Lin, Ronald M. Lechan, Thomas A. Hope, David Taïeb, Ali Cahid Civelek, Karel Pacak

Institutions: National Institutes of Health, Tufts University, University of California, San Francisco, Aix-Marseille Université, Centre Européen de Recherche en Imagerie Médicale, Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4282918334

FWCI: 4.307

Cites: 9

Cited by: 43

Related to: 10